Skip to content

The Prognostic Value of Serum Biomarkers in Osteosarcoma

The Prognostic Value of Serum Biomarkers in Osteosarcoma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05093101
Enrollment
600
Registered
2021-10-26
Start date
2021-07-12
Completion date
2021-12-22
Last updated
2022-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteosarcoma

Brief summary

Observational retrospective cohort study using laboratory data of blood tests prior to surgical and chemotherapy treatment and other histologic, clinical, and instrumental data related to patient history from digitized medical records and analysis of the same as predictors of outcomes.

Interventions

OTHERcase series review of clinical data

Extraction of pre-surgical and chemotherapy blood test laboratory data and clinical and instrumental data related to patient history from digitized medical records and analysis

Sponsors

Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to No maximum

Inclusion criteria

* Osteosarcoma diagnosed at the Pathological Anatomy of the Rizzoli Orthopaedic Institute in Bologna; * Minimum 2-year follow-up period; * Medical records, complete blood work and instrumental examinations, regular follow-up; * Patients with age ≥ 2 years;

Exclusion criteria

* Patients with osteosarcoma who have received medical treatment (surgery, radiotherapy or chemotherapy) in other hospitals prior to admission to our Institute

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of 5-year survival5 yearsEvaluation of 5-year survival in relation to histologic, laboratory, clinical, and instrumental prognostic factors

Secondary

MeasureTime frameDescription
Evaluation of the rate of local recurrence5 yearsEvaluation of the rate of local recurrence and distant metastasis in relation to histological, laboratory, clinical, and instrumental prognostic factors.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026